Joshua Boger - Vertex Pharmaceuticals Insider

Vertex Pharmaceuticals Incorporated -- USA Stock  

USD 154.6  0.03  0.0194%

Executive Director and Chairman of Science and Technology Committee

Dr. Joshua S. Boger, Ph.D., is an Independent Director of Vertex Pharmaceuticals Incorporated. Dr. Boger is the founder of Vertex and was a director since our inception in 1989. He was our Chief Executive Officer from 1992 through May 2009. He was our Chairman of our board of directors from 1997 until May 2006 and our President from our inception until December 2000, and from 2005 through February 2009. He was our Chief Scientific Officer from 1989 until May 1992. Prior to founding Vertex in 1989, Dr. Boger held the position of Senior Director of Basic Chemistry at Merck Sharp Dohme Research Laboratories in Rahway, New Jersey, where he headed both the Department of Medicinal Chemistry of Immunology Inflammation and the Department of Biophysical Chemistry
Age: 63  Chairman Since 2009      
617-341-6100  www.vrtx.com
Boger holds a B.A. in chemistry and philosophy from Wesleyan University and M.S. and Ph.D. degrees in chemistry from Harvard University.

Joshua Boger Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 7.67 % which means that it generated profit of $7.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 17.72 % meaning that it created $17.72 on every $100 dollars invested by stockholders.
The company currently holds 568.54 M in liabilities with Debt to Equity (D/E) ratio of 30.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.42 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 5 records

CHAIRMAN Since

Paul BisaroAllergan plc
2016
Miles WhiteAbbott Laboratories
1999
Norman SchwartzBio Rad Laboratories Inc
2012
Dennis GillingsQuintiles IMS Holdings Inc
2016
Roger KimmelEndo International plc
2007

Entity Summary

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 1,950 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Idea Breakdown Now
   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaixs investment ideas are predefined, sector-focused investing themes
Hide  View All  Next  Launch Idea Breakdown
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vertex Pharmaceuticals Incorporated to your portfolio

Top Management

Vertex Pharmaceuticals Leadership Team
Paul Silva, President
William Young, Director, MBA
David Altshuler, Director
Jeffrey Chodakewitz, President
Elaine Ullian, Director
Michael Parini, President
Alan Garber, Director, Ph.D
Amit Sachdev, President
Joshua Boger, Chairman
David Greenway, Director
Bruce Sachs, Director, MBA
Margaret McGlynn, Director, MBA
Michael Partridge, President
Yuchun Lee, Director, MBA
Sangeeta Bhatia, Director, Ph.D
Stuart Arbuckle, EVP
Thomas Graney, President, MBA
Terrence Kearney, Director, MBA
Ian Smith, President
Jeffrey Leiden, Chairman, Ph.D

Stock Performance

Vertex Pharmaceuticals Performance Indicators